Genscript Biotech Co. (OTCMKTS:GNNSF – Get Free Report) dropped 4.5% during mid-day trading on Tuesday . The stock traded as low as C$1.70 and last traded at C$1.70. Approximately 295 shares changed hands during mid-day trading, a decline of 93% from the average daily volume of 4,135 shares. The stock had previously closed at C$1.78.
Genscript Biotech Stock Performance
The firm’s 50-day moving average price is C$1.52 and its 200 day moving average price is C$1.42.
About Genscript Biotech
Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, the People's Republic of China, Japan, the other Asia Pacific regions, and internationally. The company operates through four segments: Life Science Services and Products; Biologics Development Services; Industrial Synthetic Biology Products; and Cell Therapy.
Recommended Stories
- Five stocks we like better than Genscript Biotech
- Golden Cross Stocks: Pattern, Examples and Charts
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- What is the Nikkei 225 index?
- Top 3 Beverage Stocks Pouring Out Profits
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for Genscript Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genscript Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
